Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in osteoclast-like giant cells

被引:13
|
作者
Nakashima, M
Nakayama, T
Ohtsuru, A
Fukada, E
Niino, D
Yamazumi, K
Naito, S
Ito, M
Sekine, I
机构
[1] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Div Sci Data Registry,Tissue & Histopathol Sect, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Dept Mol Pathol, Nagasaki 8528523, Japan
[3] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Dept Nat Med, Nagasaki 8528523, Japan
[4] Natl Nagasaki Med Ctr, Dept Pathol, Nagasaki, Japan
关键词
PTHrP; PTH/PTHrP receptor; osteoclast; giant cell tumor;
D O I
10.1078/0344-0338-00359
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Osteoclast-like giant cells (OCGC), which resemble osteoclasts at both the morphologic and immunohistochemical levels, develop in neoplastic tissue. In bone marrow, parathyroid hormone (PTH)-related peptide (PTHrP) can induce osteoclast differentiation by stimulating osteoclast progenitors through the PTH/PTHrP receptor (PPR). To evaluate the possible involvement of PTHrP in OCGC formation in tumors, we analyzed both PTHrP and PPR expression by immunohistochemistry in giant cell tumor of bone (GCTB) and anaplastic thyroid cancer (ATC) containing OCGC. In all cases of either GCTB (n = 5) or ATC (n = 4), intense staining for PTHrP was found in OCGC, but only faintly in mononuclear cells. PPR expression in OCGC was also demonstrated in 3 cases of GCTB and 2 cases of ATC. Double staining for PPR and proliferating cell nuclear antigen (PCNA) revealed that PPR was mainly expressed by PCNA-negative mononuclear cells and OCGC in these tumors. This suggests that OCGC might be derived from non-proliferating mononuclear cells by PTHrP stimulation via PPR. Furthermore, the profiles of PTHrP and PPR expression in OCGC were compared with those in the neoplastic GC found in malignancy (n = 6), osteoclasts in bone with osteoarthritis (n = 5), reactive GC, including Langhans-type and foreign body-type in pulmonary tuberculosis (n = 8), and ruptured epidermal cyst (n = 14) in order to clarify whether their distribution pattern was unique to OCGC. In all cases of malignancy, expression of both PTHrP and PPR was observed ubiquitously in neoplastic GC and mononuclear cells regardless of PCNA immunoreactivity. In contrast, in osteoclasts and reactive GC, PTHrP immunoreactivity was seen in all cases and in 7 of 22 cases, respectively, but no PPR expression was observed in either. In situ hybridization confirmed PTHrP expression at the transcriptional level in OCGC and neoplastic GC, but not in osteoclasts. Thus, although PTHrP expression was commonly observed in various types of multinucleated giant cells, their immunohistochemical profiles for PPR were distinct. We conclude that PPR might play a role during OCGC formation in GCTB and ATC.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 50 条
  • [1] Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in giant cell tumour of tendon sheath
    Nakashima, M
    Ito, M
    Ohtsuru, A
    Alipov, GK
    Matsuzaki, S
    Nakayama, T
    Yamashita, S
    Sekine, I
    JOURNAL OF PATHOLOGY, 1996, 180 (01) : 80 - 84
  • [2] Recent studies on the biological action of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in cartilage and bone
    Amizuka, N
    Henderson, JE
    White, JH
    Karaplis, AC
    Goltzman, D
    Sasaki, T
    Ozawa, H
    HISTOLOGY AND HISTOPATHOLOGY, 2000, 15 (03) : 957 - 970
  • [3] Biological action of parathyroid hormone (PTH)-related peptide (PTHrP) mediated either by the PTH/PTHrP receptor or the nucleolar translocation in chondrocytes.
    Amizuka N.
    Oda K.
    Shimomura J.
    Maeda T.
    Anatomical Science International, 2002, 77 (4) : 225 - 236
  • [4] Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells
    Otsuki, T
    Yamada, O
    Kurebayashi, J
    Sakaguchi, H
    Yata, K
    Uno, M
    Oka, T
    Yawata, Y
    Ueki, A
    LEUKEMIA & LYMPHOMA, 2001, 41 (3-4) : 397 - 409
  • [5] Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression
    Masahiro Ito
    Masahiro Nakashima
    Gabit K. Alipov
    Sumihiro Matsuzaki
    Akira Ohtsuru
    Hiroyuki Yano
    Shunichi Yamashita
    Ichiro Sekine
    Journal of Gastroenterology, 1997, 32 : 396 - 400
  • [6] Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression
    Ito, M
    Nakashima, M
    Alipov, GK
    Matsuzaki, S
    Ohtsuru, A
    Yano, H
    Yamashita, S
    Sekine, I
    JOURNAL OF GASTROENTEROLOGY, 1997, 32 (03) : 396 - 400
  • [7] Expressions of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor (PTH/PTHrP-R) in gastrointestinal stromal tumours (GISTs), leiomyomas and schwannomas
    Yoshizaki, A
    Nakayama, T
    Naito, S
    Sekine, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (02) : 133 - 137
  • [8] Co-expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in cartilaginous tumours: a marker for malignancy?
    Kunisada, T
    Moseley, JM
    Slavin, JL
    Martin, TJ
    Choong, PFM
    PATHOLOGY, 2002, 34 (02) : 133 - 137
  • [9] MODE OF ACTION OF THE PARATHYROID-HORMONE (PTH) AND THE PTH-RELATED PEPTIDE (PTHRP) IN CLASSICAL PTH-TARGET ORGANS
    URENA, P
    ABOUSAMRA, AB
    JUPPNER, H
    KONG, XF
    LEE, K
    BRINGHURST, FR
    SEGRE, GV
    ANNALES D ENDOCRINOLOGIE, 1994, 55 (05) : 133 - 141
  • [10] Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies
    Esbrit, Pedro
    Jose Alcaraz, Maria
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (10) : 1417 - 1423